Retracted retraction leaves Genomics paper intact — but authors wonder if anyone will know

Last March, the journal Genomics retracted a paper, “Discovery of transcriptional regulators and signaling pathways in the developing pituitary gland by bioinformatic and genomic approaches,” for reasons that don’t really fit into a tight lede sentence. Let’s just say that at times the problems involved both questions of authorship and the validity of the research. More on all that in a moment.

Meanwhile, things change. Now the journal, an Elsevier title, is un-retracting (that can’t be a real word, can it?) the retraction. You’d think that would please the authors, and it does to an extent. But they also wonder, legitimately, whether the original retraction will refuse to relinquish its grip on the resurrected article and consign it to database oblivion.

First, some background. Continue reading Retracted retraction leaves Genomics paper intact — but authors wonder if anyone will know

Remaining Zhiguo Wang retractions will be in the Journal of Cellular Physiology

We’ve been following the case of Zhiguo Wang, the former Montreal Heart Institute researcher who was forced to resign his post in early September following an investigation into his work. At the time of that announcement, two retractions of the Wang group’s papers — which we had reported on in August — had appeared. The Institute said they had requested three more.

We figured that meant a total of five, although the Institute wouldn’t say which they were. So when we found out about a third retraction, in the Journal of Cell Science, we said it was the first of the remaining three.

We were wrong. Continue reading Remaining Zhiguo Wang retractions will be in the Journal of Cellular Physiology

Concerns over language in PLoS One autism paper lead to brief withdrawal and correction

via Wikimedia

On September 28, PLoS One published a paper, “The Level and Nature of Autistic Intelligence II: What about Asperger Syndrome?

But rather than celebrate another publication for her CV, one of the authors, Michelle Dawson, of Centre d’Excellence en Troubles Envahissants du Développement de l’Université de Montréal (CETEDUM) in Montréal, wasn’t happy. The PLoS One editors had made some changes she didn’t like. And she let everyone on Twitter know: Continue reading Concerns over language in PLoS One autism paper lead to brief withdrawal and correction

ExpungedBob? Algae journal pulls phytoplankton paper with unwitting co-author

Mashup of Chevron-SpongeBob ad courtesy http://www.flickr.com/photos/jonathanmcintosh/

While looking at a recent retraction notice in the Journal of Phycology, the one of us with small children at home couldn’t help but imagine a conversation between cartoon character SpongeBob and his nemesis, Plankton:

SpongeBob: You used me … for land development! That wasn’t nice.

Sheldon J. Plankton: Haven’t you figured it out, SpongeBob? Nice guys finish last. Only aggressive people conquer the world. Ha ha ha ha!

SpongeBob: Well … what about aggressively nice people?

Who knew the world of phytoplankton could be so cutthroat? (Spoiler alert: we did.)

Consider: The Journal of Phycology — phycology is the study of algae and related organisms — is retracting a paper after learning that one of the three co-authors, well, wasn’t. Cyanobacteria may be the oldest known life form on earth, but the hyper-ambitious aren’t far behind.

Here’s the notice: Continue reading ExpungedBob? Algae journal pulls phytoplankton paper with unwitting co-author

Two detailed retraction notices appear in PNAS

We’ve fallen a bit behind in our coverage of retractions in the Proceedings of the National Academy of Sciences (PNAS), so we wanted to call attention to two very helpful ones from recent months.

Here’s one notice, which appeared online on August 5: Continue reading Two detailed retraction notices appear in PNAS

That’s a Mori! Seven more retractions brings latest count to 30

The other day we reported that Naoki Mori had lost his 23rd paper to retraction for image manipulation and duplication. Turns out we were wrong by a pretty wide margin.

The International Journal of Cancer has retracted seven more articles by the disgraced Japanese researcher, all for the same reasons:

The following article has been retracted through agreement between the first author and several coauthors, the journal Editor in-Chief, Peter Lichter, and John Wiley & Sons, Ltd. … After an investigation the retraction has been agreed due to inappropriate duplication of images and overlap with other published work.

The papers are as follows: Continue reading That’s a Mori! Seven more retractions brings latest count to 30

70 papers by Alirio Melendez under investigation: report

Alirio Melendez

The National University of Singapore (NUS) is reviewing about 70 papers by Alirio Melendez, a once-promising researcher whom, as we’ve reported, has been forced to retract a paper in Nature Immunology and has another paper in Science subject to an Expression of Concern.

The Straits Times, which reported the NUS investigation this weekend, says Melendez’ former team is cooperating:

In Singapore, the eight researchers involved include scientists, academics, research fellows and students from NUS and DSO National Laboratories. DSO and the personnel involved are assisting the university in its investigation.

The story continues: Continue reading 70 papers by Alirio Melendez under investigation: report

Another retraction for Naoki Mori (make that 23?)

The retraction total for Naoki Mori continues to rise.

The October issue of Biochemical and Biophysical Research Communications has retracted a 2007 paper by Mori et al for the same issues — manipulated images — that  brought down the 20-odd other papers of his since the scandal broke in late December.

Here’s the notice for the pulled paper, titled “Downregulation of citrin, a mitochondrial AGC, is associated with apoptosis of hepatocytes:” Continue reading Another retraction for Naoki Mori (make that 23?)

Does a new retraction suggest a glimmer of hope for transparency at the Journal of Neuroscience?

Believe it or not, we look for policies to praise here at Retraction Watch HQ, especially if they mark a change from approaches that we and others have criticized. So we were heartened to read this retraction notice in The Journal of Neuroscience for “Lmx1b-Controlled Isthmic Organizer Is Essential for Development of Midbrain Dopaminergic Neurons:”

The Journal of Neuroscience has received a report describing an investigation by the Shanghai Institute of Biological Sciences, Chinese Academy of Sciences, which found major data misrepresentation in the article by Guo et al. Because the results cannot be considered reliable, The Journal is retracting the paper.

The study has been cited five times since it was published in 2008, according to Thomson Scientific’s Web of Knowledge. Here’s some background on why we thought we’d have something to praise, from a Nature feature this week on retractions: Continue reading Does a new retraction suggest a glimmer of hope for transparency at the Journal of Neuroscience?

Transparency in action as genetics paper falls to fraud — and lots of it

Talk about a career-killer. The following retraction, from Genetics and Molecular Research, an online journal, spares nothing in its evisceration of an unfortunate graduate student who compiled an impressive list of transgressions in a single manuscript.

The 2010 article, titled “Genetics and biochemical analyses of sensor kinase A in Bacillus subtilis sporulation,” came from the lab of Masaya Fujita at the University of Houston. The first author was a now-former graduate student named Jean-Calvin Nguele. Whether the title is accurate, we can’t say, but apparently not much else was.

Here’s the notice: Continue reading Transparency in action as genetics paper falls to fraud — and lots of it